The iPeer2Peer (iP2P) program is an online peer support mentorship program that provides modelling and reinforcement by trained young adult peer mentors to adolescent mentees with the same condition. A quasi-experimental single-arm pre-post study design will be employed across three sites. We will recruit 40 mentees (12-17 years of age) and 12-15 mentors (18-30 years of age) who will undergo training in mentoring and the use of eHealth technology. Mentor-mentee pairings will connect over 15 weeks through video calls and text messaging to provide peer support and encourage disease self-management skills. Data will be collected using standardized instruments and interviews across three time points.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
55
Behavioral: iPeer2Peer Support Mentorship Program is an online peer support mentorship program that has been established in multiple chronic disease populations as a self-management intervention, including chronic pain and juvenile idiopathic arthritis. The iPeer2Peer program provides modeling and reinforcement by pre-screened and trained young adult peer mentors to adolescent mentees.
The Hospital for Sick Children
Toronto, Ontario, Canada
RECRUITINGAcceptability (Mentees)
Whether the innovation is agreeable, palatable or satisfactory
Time frame: 15 weeks after baseline/immediately after the intervention
Acceptability (Mentors)
Whether the innovation is agreeable, palatable or satisfactory
Time frame: Study completion, an average of 1 year
Adoption (Mentees)
The intention, initial decision or action to try or use an innovation
Time frame: Baseline to 12 weeks post-program completion
Adoption (Mentors)
The intention, initial decision or action to try or use an innovation
Time frame: Baseline to study completion, an average of 1 year
Feasibility (Mentees)
The extent to which an innovation can be used or carried out successfully in a given setting
Time frame: Baseline to 12 weeks post-program completion
Feasibility (Mentors)
The extent to which an innovation can be used or carried out successfully in a given setting
Time frame: Baseline to study completion, an average of 1 year
Appropriateness (Mentees)
The perceived fit, relevance or compatibility of the innovation for a practice setting; and/or its perceived fit to address an issue or problem
Time frame: Baseline to 12 weeks post-program completion
Appropriateness (Mentors)
The perceived fit, relevance or compatibility of the innovation for a practice setting; and/or its perceived fit to address an issue or problem
Time frame: Baseline to study completion, an average of 1 year
Level of engagement (Mentees)
Time frame: 15 weeks after baseline/immediately after the intervention
Level of engagement (Mentors)
Time frame: Study completion, an average of 1 year
Disease self-management skills (Mentees)
Time frame: Baseline to 12 weeks post-program completion
Adherence (Mentees)
Clinic attendance, completion of scheduled tests and procedures, and adolescent medication barriers scale
Time frame: Baseline to 12 weeks post-program completion
Quality of life (Mentees)
Time frame: Baseline to 12 weeks post-program completion
Perceived social support (Mentees)
Time frame: Baseline to 12 weeks post-program completion
Emotional distress (Mentees)
Time frame: Baseline to 12 weeks post-program completion
Resiliency (Mentees)
Time frame: Baseline to 12 weeks post-program completion
Assessment of mentor quality (Mentees)
Time frame: 15 weeks after baseline/immediately after the intervention
Physical and emotional symptoms (Mentors)
Time frame: Baseline to study completion, an average of 1 year
Perceived social role satisfaction (Mentors)
Time frame: Baseline to study completion, an average of 1 year
Self-efficacy (Mentors)
Time frame: Baseline to study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.